Biocare
- Company typePublic
- Founded1996
- HeadquartersShenzhen, China
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Biocare firmographics
Firmographics- Name
- Biocare
- Legal name
- 深圳邦健生物医疗设备股份有限公司
- Website
- https://biocare.com.cn
- Company type
- Public
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Biocare industry classification
Industry- Product category
- Medical Diagnostic Equipment
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Maternal & Neonatal Remote Monitoring Platforms (HLACAFAC)
- akta.pro secondary industries
- Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC)
Keywords
Where Biocare is headquartered
LocationHeadquarters
- HQ city
- Shenzhen
- HQ country
- China
- HQ region
- Asia
Offices2 records
Markets served
Biocare business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Equipment Sales: Sale of medical diagnostic equipment including ECG machines, patient monitors, fetal monitors, ultrasound systems, and defibrillators. Products are sold through distributors and direct sales channels to hospitals and healthcare facilities.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Biocare product offering
Product offeringCore offering
Biocare designs, manufactures, and distributes medical diagnostic electronic equipment, with its core product lines spanning digital ECG machines (1- to 15-channel), Holter recorders, multi-parameter patient monitors and central monitoring stations, fetal/maternal monitors including the wireless SmartFM system, diagnostic ultrasound systems, biphasic defibrillators, and syringe/infusion pumps. Products are sold to hospitals, clinics, and veterinary facilities through 2,000+ domestic distributors and international distributors in over 100 countries.
Product overview
Biocare (深圳邦健生物医疗设备股份有限公司) is a medical diagnostic equipment manufacturer established in 1996, renamed to Shenzhen Biocare Bio-Medical Equipment Co., Ltd. in 2012, offering a comprehensive portfolio of medical diagnostic instruments. The product portfolio centers on cardiac diagnostics (ECG and Holter systems), patient monitoring solutions, fetal/maternal monitoring, diagnostic ultrasound, defibrillation, and infusion management systems. The ECG portfolio spans from single-channel portable units (iE 101) through 3-channel (iE 3, iE 300), 6-channel (iE 6), 12-channel (ECG-1210, iE 12A), to 15-channel (iE 15) digital ECG systems, complemented by PC-based workstations (ECG-2000) and data management software (ECG-1000). Patient monitoring includes multi-parameter monitors (PM-900, iM 12, iM 15, iM-X12) and central monitoring systems (PM-2000). Fetal monitoring ranges from handheld dopplers (FM-200) to sophisticated fetal/maternal monitors (iC 60, iC 90) and the SmartFM intelligent wireless system. The portfolio also includes ultrasound systems (BU-907, iMage T6), biphasic defibrillators (CA360-B), syringe/infusion pumps (iP series), veterinary ECG (iE 300 Vet), and corresponding accessories. The company distributes products in over 100 countries internationally with more than 2,000 distributors in China.
Differentiator
Problem solved
Functional benefit
Products and services
- iE 15/iE 18 Digital 15-Channel ECG
Quantifiable outcome
- First digital multi-channel ECG manufacturer in China (1996)
- +1 more outcomes
Companies that use Biocare
Customer profileSegments2 records
Ideal customer profiles2 records
Biocare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Biocare partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights5 records
Biocare competitors and assessment
Company assessmentDirect peers
- Spacelabs Healthcare: U.S.-based patient monitoring and ECG specialist (subsidiary of OSI Systems) selling to hospitals globally. Spacelabs is a direct competitor in multi-parameter patient monitoring and central monitoring stations, with stronger U.S. brand presence.
- Contec Medical Systems: Chinese manufacturer of patient monitors, ECG machines, pulse oximeters and infusion pumps sold to hospitals and clinics domestically and abroad. Contec overlaps Biocare on core device categories, distribution channels (multi-tier distributors) and target customer segments.
- EDAN Instruments: Shenzhen-based medical device manufacturer with overlapping ECG, patient monitoring, fetal monitoring and ultrasound portfolios targeting hospitals and clinics globally. EDAN is a near-perfect Chinese peer to Biocare in product mix, distribution model and end customer, with a much larger listing on the Shenzhen Stock Exchange.
- Bionet: Korean medical device company producing patient monitors, ECG machines and fetal monitors for global hospital markets. Bionet competes head-to-head with Biocare in mid-tier hospital ECG and patient monitoring, especially across emerging markets in Latin America, the Middle East and Southeast Asia.
- Mortara Instrument (Hillrom / Baxter): Cardiac diagnostics specialist (ECG, Holter, stress testing) now part of Baxter following Hillrom acquisition. Mortara overlaps directly with Biocare's ECG and Holter portfolio and serves the same cardiology departments in hospitals globally.
- Fukuda Denshi: Japanese manufacturer specializing in ECG, Holter systems, patient monitors and cardiology IT. Fukuda is a direct peer in cardiac diagnostic equipment and patient monitoring, with comparable end customers (hospitals and clinics) and overlapping distribution into Asia-Pacific markets.
Broad incumbents
- GE HealthCare: Global medical technology incumbent with patient monitoring, ECG, ultrasound and diagnostic imaging portfolios serving hospitals worldwide. GE HealthCare represents the broad global incumbent Biocare benchmarks against in cardiology and monitoring, with substantially greater scale and integrated IT offerings.
- Mindray: China's largest medical device manufacturer, offering patient monitoring, ECG, defibrillation, ultrasound and in-vitro diagnostics to hospitals worldwide. Mindray is the dominant Chinese incumbent across virtually every category Biocare competes in, with materially greater scale, brand recognition and R&D budget.
- Philips (Patient Monitoring & Cardiology): Global incumbent in patient monitoring, ECG and cardiology informatics across hospitals worldwide. Philips is the premium-tier incumbent Biocare competes against in international tenders and tier-1 hospital accounts.
Others
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Biocare social profiles
Digital presenceBiocare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biocare leadership team
Management profileNumber of profiles
Profiles8 records
Biocare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biocare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biocare
What does Biocare do?
Biocare designs, manufactures, and distributes medical diagnostic electronic equipment, with its core product lines spanning digital ECG machines (1- to 15-channel), Holter recorders, multi-parameter patient monitors and central monitoring stations, fetal/maternal monitors including the wireless SmartFM system, diagnostic ultrasound systems, biphasic defibrillators, and syringe/infusion pumps. Products are sold to hospitals, clinics, and veterinary facilities through 2,000+ domestic distributors and international distributors in over 100 countries.
Is Biocare a public or private company?
Biocare is a public company. It is classified as public and is currently operating.
When was Biocare founded?
Biocare was founded in 1996. It employs 101 to 250 people.
Where is Biocare based?
Biocare is headquartered in Shenzhen, China, in the Asia region.
How does Biocare make money?
One revenue line is on record: medical Equipment Sales.
Who are Biocare's main competitors?
Direct peers on record are Spacelabs Healthcare, Contec Medical Systems, EDAN Instruments, Bionet, Mortara Instrument (Hillrom / Baxter) and Fukuda Denshi. Broad incumbents are GE HealthCare, Mindray and Philips (Patient Monitoring & Cardiology). Schiller AG is listed as an others.
Does Biocare have an API?
No public API is recorded for Biocare.
What industry is Biocare in?
Biocare's product category is Medical Diagnostic Equipment. Its primary akta.pro industry code is HLACAFAC, Maternal & Neonatal Remote Monitoring Platforms, with a secondary code of HLACAPAG, Maternal, Neonatal & Pediatric Remote Monitoring. Its NAICS code is 339112 and its SIC code is 3841.